Market by Vaccine Type, Technology, Disease Type, and Geography | Forecast 2019-2028
The detailed analysis of the global veterinary vaccines market by Triton Market Research shows that, in terms of revenue, the market is estimated to grow at a CAGR of 5.68% during the forecast years 2019-2028. It garnered $7.18 billion in 2019, and is expected to generate a revenue worth $11.80 billion by 2028.
Vaccines
help develop naturally acquired immunity by stimulating the immune system with
the help of either non-pathogenic organisms or by their immunogenic components.
Veterinary vaccines are essential to increase the welfare of the animals, and reduce
the monetary loss of their owners. These vaccines consist of attenuated and
subunit vaccines that are useful in the prevention of diseases through their
mode of action.
Also, the inclination of pet ownership by elderly people has surged in recent years, especially in developed countries. This is attributable to the rising number of elderly people living independently, along with various government programs constructed to assist in the welfare of pets owned by the geriatric population. Moreover, the animal vaccine market has experienced moderate growth in the last few years, owing to the emerging diseases affecting livestock and companion animals.
The
study aims to get an overview of the veterinary vaccines market in terms of
various factors. Within this report, the market definition and the key insights
regarding the market have been discussed. Also, industry components, regulatory
framework, vendor scorecard, Porter's five forces model, and market
attractiveness index have been studied in detail.
The
growing prevalence of zoonotic diseases and rising livestock diseases are
primarily driving the veterinary vaccines market growth. However, the adverse
effects of post-vaccination and shortage of skilled farmworkers are obstructing
the growth of this market.
Key
opportunities, such as the increasing number of initiatives by government
agencies and growth in the momentum of pet ownership, can be leveraged by the
market to reach the projected growth. However, the high costs of vaccinations
is a challenge faced by this market.
Geographies
covered in the veterinary vaccines market are:
• North America: Canada and United
States
• Europe: Italy, Germany, Spain, United
Kingdom, France, Russia, and Rest of Europe
• Asia-Pacific: Japan, China, India,
South Korea, ASEAN countries, New Zealand & Australia, and Rest of
Asia-Pacific
• Latin America: Mexico, Brazil,
Argentina, and Rest of Latin America
• Middle East and Africa
The
veterinary vaccines market has been segmented as follows:
• By Vaccine Type
o Companion
vaccine
• Canine vaccine
• Feline vaccine
• Equine vaccine
o Livestock
vaccine
• Porcine vaccine
• Bovine vaccine
• Poultry vaccine
• Aquaculture vaccine
• Other livestock vaccines
• By Technology
o Recombinant
Vaccine
o Live
Attenuated Vaccine
o Inactivated
Vaccine
o Toxoid
Vaccine
o Other
Technology
• By Disease Type
o Canine
Disease
o Porcine
Disease
o Bovine
Disease
o Poultry
Disease
o Aquaculture
Disease
o Other
Disease Type
The
key players engaged in the veterinary vaccines market are Zoetis, Neogen
Corporation, Ceva Sante Animale, Elanco (Eli Lilly And Company), HIPRA, Merck
& Co, Boehringer Ingelheim Animal Health GmbH, Phibro Animal Health Corp, Hester
Biosciences Limited, Romvac Company SA, Virbac SA, Vaxxinova GmbH-Germany, Anicon
Labor GmbH, and Hygieia Biological Laboratories.
The
strategic analysis for each of these companies has been covered in detail. The veterinary
vaccines market by company profiles helps to dive into the data about the key
market players in this market.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Test Types, Technolo ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT1. GLOBAL
VETERINARY VACCINES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. IMPACT
OF COVID-19 ON VETERINARY VACCINES MARKET
2.4. INDUSTRY
COMPONENTS
2.5. REGULATORY
FRAMEWORK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. MARKET
DRIVERS
2.8.1. GROWTH
IN PREVALENCE OF ZOONOTIC DISEASES
2.8.2. RISE
IN LIVESTOCK DISEASES
2.9. MARKET
RESTRAINTS
2.9.1. ADVERSE
EFFECTS OF POST-VACCINATION
2.9.2. SHORTAGE
OF SKILLED FARMWORKERS
2.10. MARKET OPPORTUNITIES
2.10.1. INCREASE IN NUMBER OF
INITIATIVES BY GOVERNMENT AGENCIES
2.10.2. GROWTH IN MOMENTUM OF PET
OWNERSHIP
2.11. MARKET CHALLENGE
2.11.1. HIGH COSTS OF VACCINATIONS
3. GLOBAL
VETERINARY VACCINES MARKET OUTLOOK - BY VACCINE TYPE
3.1. LIVESTOCK
VACCINE
3.1.1. PORCINE
VACCINE
3.1.2. BOVINE
VACCINE
3.1.3. POULTRY
VACCINE
3.1.4. AQUACULTURE
VACCINE
3.1.5. OTHER
LIVESTOCK VACCINE
3.2. COMPANION
VACCINE
3.2.1. CANINE
VACCINE
3.2.2. FELINE
VACCINE
3.2.3. EQUINE
VACCINE
4. GLOBAL
VETERINARY VACCINES MARKET OUTLOOK - BY TECHNOLOGY
4.1. LIVE
ATTENUATED VACCINE
4.2. INACTIVATED
VACCINE
4.3. RECOMBINANT
VACCINE
4.4. TOXOID
VACCINE
4.5. OTHER
TECHNOLOGY
5. GLOBAL
VETERINARY VACCINES MARKET OUTLOOK - BY DISEASE TYPE
5.1. CANINE
DISEASE
5.2. PORCINE
DISEASE
5.3. BOVINE
DISEASE
5.4. POULTRY
DISEASE
5.5. AQUACULTURE
DISEASE
5.6. OTHER
DISEASE TYPE
6. GLOBAL
VETERINARY VACCINES MARKET - REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY VACCINE TYPE
6.1.1.1. MARKET
BY LIVESTOCK VACCINE
6.1.1.2. MARKET
BY COMPANION VACCINE
6.1.2. MARKET
BY TECHNOLOGY
6.1.3. MARKET
BY DISEASE TYPE
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. THE
UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
BY VACCINE TYPE
6.2.1.1. MARKET
BY LIVESTOCK VACCINE
6.2.1.2. MARKET
BY COMPANION VACCINE
6.2.2. MARKET
BY TECHNOLOGY
6.2.3. MARKET
BY DISEASE TYPE
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. THE
UNITED KINGDOM
6.2.4.2. FRANCE
6.2.4.3. GERMANY
6.2.4.4. ITALY
6.2.4.5. RUSSIA
6.2.4.6. SPAIN
6.2.4.7. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY VACCINE TYPE
6.3.1.1. MARKET
BY LIVESTOCK VACCINE
6.3.1.2. MARKET
BY COMPANION VACCINE
6.3.2. MARKET
BY TECHNOLOGY
6.3.3. MARKET
BY DISEASE TYPE
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. AUSTRALIA
& NEW ZEALAND
6.3.4.5. SOUTH
KOREA
6.3.4.6. ASEAN
COUNTRIES
6.3.4.7. REST
OF ASIA-PACIFIC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY VACCINE TYPE
6.4.1.1. MARKET
BY LIVESTOCK VACCINE
6.4.1.2. MARKET
BY COMPANION VACCINE
6.4.2. MARKET
BY TECHNOLOGY
6.4.3. MARKET
BY DISEASE TYPE
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. ARGENTINA
6.4.4.4. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY VACCINE TYPE
6.5.1.1. MARKET
BY LIVESTOCK VACCINE
6.5.1.2. MARKET
BY COMPANION VACCINE
6.5.2. MARKET
BY TECHNOLOGY
6.5.3. MARKET
BY DISEASE TYPE
6.5.4. REGIONAL
ANALYSIS
7. COMPANY
PROFILES
7.1. BOEHRINGER
INGELHEIM ANIMAL HEALTH GMBH
7.2. CEVA
SANTE ANIMALE
7.3. HYGIEIA
BIOLOGICAL LABORATORIES
7.4. ANICON
LABOR GMBH
7.5. PHIBRO
ANIMAL HEALTH CORP
7.6. ROMVAC
COMPANY SA
7.7. ELANCO
(ELI LILLY AND COMPANY)
7.8. VAXXINOVA
GMBH-GERMANY
7.9. ZOETIS
7.10. HESTER BIOSCIENCES LIMITED
7.11. HIPRA
7.12. VIRBAC SA
7.13. MERCK & CO
7.14. NEOGEN CORPORATION
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL
VETERINARY VACCINES MARKET, BY REGION, 2019-2028 (IN $ MILLION)
TABLE 2: MARKET
SNAPSHOT - VETERINARY VACCINE
TABLE 3: VENDOR
SCORECARD
TABLE 4: GLOBAL
VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)
TABLE 5: GLOBAL
LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 6: COMMERCIALLY
AVAILABLE PORCINE VACCINES
TABLE 7: COMMERCIALLY
AVAILABLE POULTRY VACCINES
TABLE 8: GLOBAL
COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 9: COMMERCIALLY
AVAILABLE CANINE VACCINES
TABLE 10: COMMERCIALLY
AVAILABLE FELINE VACCINES
TABLE 11: COMMERCIALLY
AVAILABLE EQUINE VACCINES
TABLE 12: GLOBAL
VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)
TABLE 13: GLOBAL
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)
TABLE 14: GLOBAL
VETERINARY VACCINES MARKET, BY REGION, 2019-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA
VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA
LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA
COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA
VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA
VETERINARY VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 21: EUROPE
VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)
TABLE 22: EUROPE
LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 23: EUROPE
COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 24: EUROPE
VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)
TABLE 25: EUROPE
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)
TABLE 26: EUROPE
VETERINARY VACCINES, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC
LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC
COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 33: LATIN AMERICA
VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)
TABLE 34: LATIN AMERICA
LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 35: LATIN AMERICA
COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 36: LATIN AMERICA
VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)
TABLE 37: LATIN AMERICA
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)
TABLE 38: LATIN AMERICA
VETERINARY VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 39: MIDDLE EAST
AND AFRICA VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $
MILLION)
TABLE 40: MIDDLE EAST
AND AFRICA LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 41: MIDDLE EAST
AND AFRICA COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 42: MIDDLE EAST
AND AFRICA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)
TABLE 43: MIDDLE EAST AND AFRICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)
FIGURE 1: GLOBAL
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 2: GLOBAL
VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 3: GLOBAL
LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 4: GLOBAL
LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 5: GLOBAL
LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 6: GLOBAL
LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 7: GLOBAL
LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 8: GLOBAL
VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 9: GLOBAL
COMPANION VACCINE MARKET, BY CANINE VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 10: GLOBAL
COMPANION VACCINE MARKET, BY FELINE VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 11: GLOBAL
COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 12: GLOBAL
VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2019-2028 (IN $
MILLION)
FIGURE 13: GLOBAL
VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 14: GLOBAL
VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 15: GLOBAL
VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 16: GLOBAL
VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2019-2028 (IN $ MILLION)
FIGURE 17: GLOBAL
VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2019-2028 (IN $ MILLION)
FIGURE 18: GLOBAL
VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2019-2028 (IN $ MILLION)
FIGURE 19: GLOBAL
VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2019-2028 (IN $ MILLION)
FIGURE 20: GLOBAL
VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2019-2028 (IN $ MILLION)
FIGURE 21: GLOBAL
VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2019-2028 (IN $ MILLION)
FIGURE 22: GLOBAL
VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2019-2028 (IN $ MILLION)
FIGURE 23: THE UNITED
STATES VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 24: CANADA
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 25: THE UNITED
KINGDOM VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 26: FRANCE
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 27: GERMANY
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 28: ITALY
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 29: RUSSIA
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 30: SPAIN
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 31: REST OF
EUROPE VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 32: CHINA
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 33: JAPAN
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 34: INDIA
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 35: AUSTRALIA
& NEW ZEALAND VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 36: SOUTH KOREA
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 37: ASEAN
COUNTRIES VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 38: REST OF
ASIA-PACIFIC VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 39: BRAZIL
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 40: MEXICO VETERINARY
VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 41: ARGENTINA
VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 42: REST OF
LATIN AMERICA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)